×

Medical treatment composition comprising mammalian dental pulp stem cells

  • US 10,328,103 B2
  • Filed: 03/15/2013
  • Issued: 06/25/2019
  • Est. Priority Date: 01/03/2009
  • Status: Active Grant
First Claim
Patent Images

1. A medical treatment composition comprising:

  • a dental pulp suspension including viable mammalian dental pulp stem cells, mammalian dental pulp proteins, and extracellular matrix proteins, wherein the suspension has not been digested by collagenase and the stem cells have not been cultured; and

    a non-naturally occurring cryoprotectant, the cryoprotectant being dimethyl sulfoxide;

    wherein the composition is in a form that is safe for injection into pathologic or injured tissue.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×